Literature DB >> 26612535

Epithelial-mesenchymal transition: Untangling EMT's functions.

Sarah Seton-Rogers.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26612535     DOI： 10.1038/nrc.2015.6

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  2 in total

1.  Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

Authors:  Xiaofeng Zheng; Julienne L Carstens; Jiha Kim; Matthew Scheible; Judith Kaye; Hikaru Sugimoto; Chia-Chin Wu; Valerie S LeBleu; Raghu Kalluri
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

2.  Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.

Authors:  Kari R Fischer; Anna Durrans; Sharrell Lee; Jianting Sheng; Fuhai Li; Stephen T C Wong; Hyejin Choi; Tina El Rayes; Seongho Ryu; Juliane Troeger; Robert F Schwabe; Linda T Vahdat; Nasser K Altorki; Vivek Mittal; Dingcheng Gao
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962
  2 in total
  32 in total

1.  Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.

Authors:  Haitao Feng; Jin-Jian Lu; Yitao Wang; Lixia Pei; Xiuping Chen
Journal:  Cell Adh Migr       Date:  2017-02-02       Impact factor: 3.405

Review 2.  Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition.

Authors:  Anai N Kothari; Matthew L Arffa; Victor Chang; Robert H Blackwell; Wing-Kin Syn; Jiwang Zhang; Zhiyong Mi; Paul C Kuo
Journal:  J Clin Med       Date:  2016-03-23       Impact factor: 4.241

3.  Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer.

Authors:  Yujuan Zhou; Qianjin Liao; Yaqian Han; Jie Chen; Zhigang Liu; Hang Ling; Jing Zhang; Wenjuan Yang; Linda Oyang; Longzheng Xia; Li Wang; Heran Wang; Lei Xue; Hui Wang; Bingqiang Hu
Journal:  J Cancer       Date:  2016-10-23       Impact factor: 4.207

4.  Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response.

Authors:  Jeroen Dekervel; Ashenafi Bulle; Petra Windmolders; Diether Lambrechts; Eric Van Cutsem; Chris Verslype; Jos van Pelt
Journal:  Transl Oncol       Date:  2016-12-15       Impact factor: 4.243

Review 5.  For robust big data analyses: a collection of 150 important pro-metastatic genes.

Authors:  Yan Mei; Jun-Ping Yang; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2017-01-21

6.  Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway.

Authors:  Panpan Zhou; Chunling Wang; Zebin Hu; Wenruo Chen; Wentao Qi; Aike Li
Journal:  BMC Cancer       Date:  2017-12-04       Impact factor: 4.430

7.  Elevated expression of Derlin-1 associates with unfavorable survival time of squamous cell carcinoma of the head and neck and promotes its malignance.

Authors:  Leiming Pi; Gangcai Zhu; Li She; Ming Wei; Guancheng Liu; Changhan Chen; Di Hu; Fusen Peng; Haolei Tan; Yong Liu; Donghai Huang; Yongquan Tian; Xin Zhang
Journal:  J Cancer       Date:  2017-07-21       Impact factor: 4.207

8.  Overexpression of PAK1 Correlates with Aberrant Expression of EMT Markers and Poor Prognosis in Non-Small Cell Lung Cancer.

Authors:  Zhiying Yang; Heran Wang; Longzheng Xia; Linda Oyang; Yujuan Zhou; Baihua Zhang; Xiaoyan Chen; Xia Luo; Qianjin Liao; Jianping Liang
Journal:  J Cancer       Date:  2017-06-01       Impact factor: 4.207

9.  Dynamic analysis of the mesenchymal-epithelial transition of blood-brain barrier forming glia in Drosophila.

Authors:  Tina Schwabe; Xiaoling Li; Ulrike Gaul
Journal:  Biol Open       Date:  2017-02-15       Impact factor: 2.422

10.  PADI1 contributes to EMT in PAAD by activating the ERK1/2-p38 signaling pathway.

Authors:  Tengfei Ji; Keqiang Ma; Liang Chen; Tiansheng Cao
Journal:  J Gastrointest Oncol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.